Validation of a screening questionnaire for the presence of neuropsychiatric symptoms in patients with systemic lupus erythematosus in clinical practice
Authors:
V. Henyšová; M. Olejárová; R. Moravcová
Authors place of work:
Revmatologický ústav, 1. lékařská fakulta Univerzity Karlovy, Praha
Published in the journal:
Čes. Revmatol., 24, 2016, No. 4, p. 154-161.
Category:
Original Papers
Summary
Neuropsychiatric lupus (NPSLE) is one of the most common types of organ damage in systemic lupus erythematosus (SLE) and includes a total of 19 clinical syndromes affecting the central and peripheral nervous system. To simplify diagnosis and detection of early involvement in NPSLE a working group of experts on NPSLE designed a questionnaire for screening of neuropsychiatric impairment in patients with established SLE.
Objective:
The objective was to create a Czech version of the screening questionnaire in patients with systemic lupus erythematosus, for the presence of neuropsychiatric symptoms in routine clinical practice, and to perform its validation.
Patients and Methods:
The questionnaire was translated independently by two rheumatologists, and both translations were then compared by the group of authors, discussed and unified. The resulting questionnaire was translated back into English and compared with the original version, and the final version of the Czech translation of the questionnaire was created. This version was presented to 41 patients with SLE. To assess the clarity and relevance of the questions we used the method of feedback from respondents.
Results:
An overall score of 17 points, and thus the possibility of the presence of NPSLE, was reached by 17 respondents. If the neurological component was assessed only, the screening was positive in 24 patients (58.3%). The questionnaire was understandable for all respondents.
Conclusion:
The Czech, linguistically validated version of the screening questionnaire for NPSLE demonstrated applicability for an approximate assessment of the presence of neuropsychiatric symptoms, clarity and relevance to the problems of patients. This short questionnaire containing a total of 27 questions in two sections can already be used in routine clinical practice.
Key words:
Systemic lupus erythematosus, neuropsychiatric lupus, screening
Zdroje
1. Bijlsma JWJ, Hachulla E, et al. EULAR textbook on Rheumatic Diseases. Ingram International, London, 2015: 531–537.
2. Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010; 6(6): 358–67.
3. Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs 2016; 76 (4): 459 –83.
4. Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S, et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford), 2015. 54(5): 891–8.
5. Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res (Hoboken) 2011; 63 (Suppl 11): S413–9.
6. Kasama TA, Maeoka A, Oguro N. Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases. Clin Med Insights Arthritis Musculoskelet Disord 2016; 9: 1–8.
7. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58(8): 1214–20.
8. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69(3): 529–35.
9. Joseph FG, Scolding NJ. Neurolupus. Pract Neurol 2010; 10(1): 4–15.
10. Sibbitt WL, Jr., Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29(7): 1536–42.
11. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus. Isr Med Assoc J 2015; 17(3): 171–8.
12. Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 2015; 14(2): 153–9.
13. Pamfil C, Fanouriakis A, Damian L, Rinzis M, Sidiropoulos P, Tsivgoulis G, Rednic S et al. EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford) 2015; 54(7): 1270–8.
14. Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol 2011; 9(3): 449–57.
15. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42(4): 599–608.
16. Ainiala, H., Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsänoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001; 45(5): 419–23.
17. Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004; 51(5): 810–8. 18.
18. Tom T, Brody M, Valabhji A, Turner L, Molgaard C, Rothrock J. Validation of new instrument for determinig migraine prevalence: the UCSD Migraine Questionaire. Neurology 1994; 44: 925-8.
19. Tani C, Palagini L, Moraes-Fontes MF, Carli L, Mauri M, Bombardieri S, et al. Neuropsychiatric questionnaires in systemic lu-pus erythematosus. Clin Exp Rheumatol 2014; 32(5 Suppl 85): S-59–64.
20. Tjensvoll AB, Gøransson LG, Harboe E, Kvaløy JT, Omdal R. High headache-related disability in patients with systemic lupus erythematosus and primary Sjogren's syndrome. Eur J Neurol 2014; 21(8): 1124–30.
21. Rybak, D, Jordan N, Schwartz N, Rubinstein T, Freilich B, Blanco I, et al. “Point of Care” Neurocognitive Testing for Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). Abstrakt. 2014 ACR/ARHP Annual Meeting, Boston 2014. Available from: http://acrabstracts.org/abstract/point-of-care-neurocognitive-testing-for-neuropsychiatric-syste mic-lupus-erythematosis-npsle/.
22. Beck AT, Ward CH, Mendelson M, Mock J, Erbauch J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71.
23. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12(6): 371–9.
24. Denburg SD, Stewart KE, Hart LE, Denburg JA. How "soft" are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus. J Rheumatol 2003; 30(5): 1006–10.
25. Beltrao SM, Gigante LB, Zimmer DB, Zimmermann PR, Schmoeller D, Batistella F, et al. Psychiatric symptoms in patients with systemic lupus erythematosus: frequency and association with disease activity using the Adult Psychiatric Morbidity Questionnaire. Rev Bras Reumatol 2013; 53(4): 328–34.
26. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69(12): 2074–82.
27. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, et al. The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice. Lupus 2011; 20(5): 485–92.
28. Font J, Cervera R. 1982 revised criteria for classification of systemic lupus erythematosus--ten years later. Lupus 1993; 2(5): 339–41.
Štítky
Dermatology & STDs Paediatric rheumatology RheumatologyČlánok vyšiel v časopise
Czech Rheumatology
2016 Číslo 4
Najčítanejšie v tomto čísle
- Recommendations for the treatment of psoriatic arthritis
- Validation of a screening questionnaire for the presence of neuropsychiatric symptoms in patients with systemic lupus erythematosus in clinical practice
- Comorbidities in spondyloarthropathies